Athera Biotechnologies and Boehringer Ingelheim Corporation Enter Into an Option Agreement on a Novel Therapy for Atherosclerosis
6/19/2013 9:38:50 AM
More...
|
Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF
6/17/2013 9:22:38 AM
More...
|
Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Statement on the American Diabetes Association Request for Independent Review of Incretin-Based Therapies
6/14/2013 10:06:52 AM
More...
|
Boehringer Ingelheim Corporation Release: New Long-Term Data Published in Circulation Reinforce Safety Profile of Pradaxa® (dabigatran etexilate mesylate)
6/14/2013 8:38:25 AM
More...
|
Swedish Orphan Biovitrum Gets FDA Approval to Manufacture Substance for Kineret® With Partner Boehringer Ingelheim Corporation
6/11/2013 9:48:34 AM
More...
|
Swedish Orphan Biovitrum Gets FDA Approval to Manufacture Substance for Kineret® With Partner Boehringer Ingelheim Corporation
6/11/2013 9:14:25 AM
More...
|
Boehringer Ingelheim Corporation's Investigational Faldaprevir+ Achieved Viral Cure in 88% of Treatment-Naive Hepatitis C Patients in Asia
6/10/2013 10:17:40 AM
More...
|
Week in Review: Boehringer Ingelheim Corporation to Build Biopharma CMO in Shanghai
6/10/2013 9:16:34 AM
More...
|
Boehringer Ingelheim Corporation to Build Biopharma Facility in China, Creating 65 Jobs
6/7/2013 7:52:14 AM
More...
|
Boehringer Ingelheim Corporation Release: LUME-Lung 1: Nintedanib* Plus Chemotherapy Extends the Life of Lung Cancer Patients With Adenocarcinoma
6/3/2013 1:15:00 PM
More...
|
|